Literature DB >> 793538

Role of chronic hepatitis in development of thalassaemic liver disease.

G Masera, G Jean, G Gazzola, M Novakova.   

Abstract

Liver function and the presence of HBsAg and anti-HBsAg were studied in 90 hypertransfused thalassaemic children. Increased serum transaminases were found in 62 patients, and persisted from more than 6 months in 45 cases. Liver biopsy in this latter group led to a diagnosis of 14 cases of chronic persistent hepatitis, 9 cases of aggressive hepatitis, and 3 cases of hepatic fibrosis. In Italy thalassaemic children undergoing hypertransfusion therapy frequently encounter SH virus infection, with a consequent hepatitis that is generally anicteric and unrecognized unless systematically sought. In a liver already stressed by the concomitant iron overload, hepatitis infection might thus play a key role in the evolution of cirrhosis which frequently affects thalassaemics.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793538      PMCID: PMC1546247          DOI: 10.1136/adc.51.9.680

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Transfusion-associated hepatitis not due to viral hepatitis type A or B.

Authors:  S M Feinstone; A Z Kapikian; R H Purcell; H J Alter; P V Holland
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

Review 2.  Histological diagnosis of viral hepatitis.

Authors:  V J Desmet; J De Groot
Journal:  Clin Gastroenterol       Date:  1974-05

3.  A serologic study of cytomegalovirus infections associated with blood transfusions.

Authors:  A M Prince; W Szmuness; S J Millian; D S David
Journal:  N Engl J Med       Date:  1971-05-20       Impact factor: 91.245

Review 4.  Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects.

Authors:  T C Chalmers; H J Alter
Journal:  N Engl J Med       Date:  1971-09-09       Impact factor: 91.245

5.  The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy.

Authors:  R A Risdon; D M Flynn; M Barry
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

6.  Experimental siderosis and liver injury in the rhesus monkey.

Authors:  I Nath; S K Sood; N C Nayak
Journal:  J Pathol       Date:  1972-02       Impact factor: 7.996

7.  Australia antigen and antibody in transfused children with thalassaemia.

Authors:  A Vierucci; W T London; B S Blumberg; A I Sutnick; F Ragazzini
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

8.  The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.

Authors:  J Economidou; M Constantoulakis; O Augustaki; P E Taylor; A J Zuckerman; P M Baines; M A Bryceson
Journal:  Vox Sang       Date:  1970 Sep-Oct       Impact factor: 2.144

9.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06

10.  Prevalence of Au-Ag and Au-Ab in transfused children with thalassaemia in Greece.

Authors:  C Kattamis; V Syriopoulou; Y Davri-Karamouzi; D Demetriou; N Matsaniotis
Journal:  Arch Dis Child       Date:  1974-06       Impact factor: 3.791

View more
  11 in total

1.  Lymphocyte changes in beta-thalassaemia major.

Authors:  S Musumeci; G Schiliro; M A Romeo; A Sciotto; A Rosalba; G Pizzarelli
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

2.  Management of thalassaemia major.

Authors:  B Modell; M Petrou
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

3.  Occurrence of circulating immune complexes in beta-thalassaemia major.

Authors:  P Casali; P Borzini; D Vergani; G Mieli-Vergani; G Masera; C Zanussi
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

4.  Hepatitis B virus infection in thalassaemia major treated in London and Athens.

Authors:  G Mieli-Vergani; D Vergani; Y White; A P Mowat; B Wonke; C J Kennedy; A Karameau; D Politis; M Laulicht; A V Hoffbrand
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

5.  Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies.

Authors:  K Thakerngpol; S Fucharoen; P Boonyaphipat; K Srisook; S Sahaphong; V Vathanophas; T Stitnimankarn
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

6.  Serum ferritin, liver iron stores, and liver histology in children with thalassaemia.

Authors:  S de Virgiliis; G Sanna; G Cornacchia; F Argiolu; V Murgia; M Porcu; A Cao
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

7.  Cirrhosis associated with multiple transfusions in thalassaemia.

Authors:  G Jean; S Terzoli; R Mauri; L Borghetti; A Di Palma; A Piga; M Magliano; M Melevendi; M Cattaneo
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

8.  Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.

Authors:  G A Moroni; G Piacentini; S Terzoli; G Jean; G Masera
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

9.  Sequential study of liver biopsy in thalassaemia.

Authors:  G Masera; G Jean; V Conter; S Terzoli; R A Mauri; M Cazzaniga
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

10.  Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.

Authors:  S De Virgiliis; G Fiorelli; S Fargion; G Cornacchia; G Sanna; P Cossu; V Murgia; A Cao
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.